NPI registry status
Active
2026 NPPES data Clinical Neurophysiology Physician NPI 1255516019 M.D.
Verify on CMS → Marat Reyzelman, M.D.
Clinical Neurophysiology Physician in Marietta, Georgia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 637 in Clinical Neurophysiology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 563 beneficiaries · Clinical Neurophysiology Physician avg: 2K
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
92.9/100
▲ 9 pts above national avg 83.5 · Exceptional
Industry payments
$8.6K
47 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Marat Reyzelman, M.D. reported a CMS MIPS final score of 92.9/100 - above the 83.5 national average - and filed 4,211 Medicare Part D claims in 2023.
- 92.9/100
- MIPS score · +9 vs avg
- 4K
- Part D claims, 2023
- 91%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Marat Reyzelman, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1255516019), first enumerated 12/29/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 4,211 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 92.9/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$8.6K in reported industry payments (47 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1255516019 · Clinical Neurophysiology Physician
NPI-10 · ENUM-MID · TAX-NARROW · MIPS-ABOVE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1255516019
- ENUM-MID 2007
- TAX-NARROW 637
- MIPS-ABOVE 92.9/100
- RX-MID 4,211
- BOOK-THIN 8 in Georgia
- PHOTO-FINISH Irene Semenov · ±0.2
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Robert Gardner ·…
Robert Gardner
92.6 MIPS pts
- Reyzelman · this…
Reyzelman · this provider
92.9 MIPS pts
- Irene Semenov · …
Irene Semenov
93.1 MIPS pts
- Stephen Gollomp …
Stephen Gollomp
93.5 MIPS pts
- Aliza Alter · hi…
Aliza Alter
93.7 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Marat Reyzelman, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
93 ≥ 66th percentile 66% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Marat Reyzelman, M.D. sits
This provider among clinical neurophysiology physician peers
Across the 174 clinical neurophysiology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Marat Reyzelman, M.D. writes more Part D claims than 87% of them and scores higher on MIPS quality than 66% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one clinical neurophysiology physician peer from a representative sample of 60; the gold marker is Marat Reyzelman, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Marat Reyzelman, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Marat Reyzelman, M.D.?
High performer (top quartile)Primary specialty
Clinical Neurophysiology Physician
Medicare Part D claims
4,211 176% vs specialty avg
MIPS final score
92.9/100 9.4 pts vs avg
Specialty distribution in Georgia
How Clinical Neurophysiology Physician compares to other specialties among Georgia providers
Medicare quality performance, MIPS
Marat Reyzelman, M.D.'s 2023 MIPS final score plotted against the Clinical Neurophysiology Physician national average
- MIPS Final Score
- 92.9/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1255516019 |
|---|---|
| Specialty | Clinical Neurophysiology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 12/29/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
92.9348
Final Score
Measured-score avg: 83.5
80.3814
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Marat Reyzelman, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Wellstar Medical Group LLC
Lagrange, GA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Marat Reyzelman, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$8.6K
Largest payer
Sarepta Therapeutics, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Marat Reyzelman, M.D. - brand share 9.0%
Clinical Neurophysiology Physician average
9% brand-name claims vs 91% generic, on 4,211 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
4,211
Total Claims
$1.1M
Total Drug Cost
563
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 6,862
- Total Day Supply
- 198,935
- Brand vs Generic
- 9% brand / 91% generic
- Brand Drug Cost
- $875K
- Generic Drug Cost
- $202K
- Opioid Claims
- 108 (2.6% rate)
Patient Demographics
- Average Patient Age
- 73.2 years
- Avg HCC Risk Score
- 1.41
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 81, 65-74: 202, 75-84: 208, 85+: 72
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Marat Reyzelman, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Gabapentin
Gabapentin
456 claims
- Donepezil Hcl
Donepezil Hcl
350 claims
- Memantine Hcl
Memantine Hcl
277 claims
- Carbidopa-Levodopa
Carbidopa-Levodopa
205 claims
- Topiramate 179
Topiramate
179 claims
- Primidone 127
Primidone
127 claims
- Quetiapine Fumarate 109
Quetiapine Fumarate
109 claims
- Levetiracetam 102
Levetiracetam
102 claims
| Drug | Claims |
|---|---|
| Gabapentin | 456 |
| Donepezil Hcl | 350 |
| Memantine Hcl | 277 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 205 |
| Topiramate | 179 |
| Primidone | 127 |
| Quetiapine Fumarate | 109 |
| Levetiracetam | 102 |
| Pregabalin | 100 |
| Clonazepam | 88 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Clinical Neurophysiology Physician Overview
How Marat Reyzelman, M.D. fits within the Clinical Neurophysiology Physician landscape nationally.
637
Clinical Neurophysiology Physician Providers in US
50
States with Clinical Neurophysiology Physician
1,523
Avg Claims per Provider
Marat Reyzelman, M.D.'s 4,211 claims are above the specialty average of 1,523.
Nationwide Clinical Neurophysiology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Reyzelman, both outside Georgia so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (92.9 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Clinical Neurophysiology Physician Providers in Georgia
Other clinicians with the same primary specialty enrolled in Georgia, drawn from the same CMS NPPES roster as Reyzelman.
One of 8 Clinical Neurophysiology Physician providers enrolled in Georgia, 5 are shown here.
Dr. Joseph Hormes
M.D., M.P.H.
Marietta, GA
Dr. Craig Johnson
MD
Marietta, GA
Dr. Ashish Kabir
M.D.
Dalton, GA
Dr. Matthew Morton
MD
Atlanta, GA
Dr. Rosita Shivdat-Nanhoe
MD
Warner Robins, GA
Compare Clinical Neurophysiology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Marat Reyzelman, M.D.'s specialty? ▼
Marat Reyzelman, M.D. specializes in Clinical Neurophysiology Physician and practices in Marietta, Georgia. Credentials: M.D..
How much does Marat Reyzelman, M.D. prescribe under Medicare Part D? ▼
In 2023, Marat Reyzelman, M.D. wrote 4,211 Medicare Part D claims totaling $1.1M in drug costs for 563 beneficiaries.
What is Marat Reyzelman, M.D.'s Medicare quality score? ▼
Marat Reyzelman, M.D. has a CMS MIPS Final Score of 92.9/100 (Quality: 80.4). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Marat Reyzelman, M.D. located? ▼
Marat Reyzelman, M.D. is located at 780 CANTON ROAD, Marietta, GA, 30060. Phone: (770) 422-3602.
What is Marat Reyzelman, M.D.'s NPI number? ▼
Marat Reyzelman, M.D.'s National Provider Identifier (NPI) is 1255516019, issued on 12/29/2007.
Does Marat Reyzelman, M.D. prescribe more brand-name or generic drugs? ▼
Marat Reyzelman, M.D.'s prescribing is 9% brand-name and 91% generic drugs by claim count, with $875K in brand drug costs.
Does Marat Reyzelman, M.D. prescribe opioids? ▼
Yes, Marat Reyzelman, M.D. had 108 opioid claims in 2023 with an opioid prescribing rate of 2.6%.
How many Clinical Neurophysiology Physician providers are there in the US? ▼
There are 637 Clinical Neurophysiology Physician providers across 50 states in the US. The average Clinical Neurophysiology Physician provider writes 1,523 Medicare Part D claims per year.
What drugs does Marat Reyzelman, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Marat Reyzelman, M.D.'s most frequently prescribed drugs include Gabapentin, Donepezil Hcl, Memantine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Marat Reyzelman, M.D. accept Medicare? ▼
Marat Reyzelman, M.D. appears in CMS Medicare data with 4,211 Part D claims and 563 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Marat Reyzelman, M.D.'s credentials? ▼
Marat Reyzelman, M.D.'s NPI is 1255516019 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.